Trial Profile

Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting: The ALPHEUS Study

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Feb 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Jan 2024 Results assessing the impact of the P2Y12 inhibitor loading time on periprocedural myocardial necrosis, published in the Canadian Journal of Cardiology
28 Aug 2023 Results of post hoc analysis assessing the the frequency and outcomes of complex PCI in stable coronary patients and the efficacy of ticagrelor versus clopidogrel in these patients randomized in the ALPHEUS trial, presented at the ESC Congress 2023 - Annual Congress of the European Society of Cardiology.
28 Dec 2020 Results of meta-analysis comparing safety and efficacy of pP2Y12-I versus Clopidogrel in patients with CAD undergoing elective PCI published in the American Journal of Cardiology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com